The "exercise mimetic" research peptide. Bionix Labs Oral SLU-PP-332 SEDDS Suspension delivers 20 mg/mL in a 50 mL bottle — a ready-to-use oral formulation that lasts 50 days at the standard 20 mg/day dose. Shipped Australia-wide.

A$170.00AUD
Quantity
Line total: A$170.00
| Formulation | Oral SLU-PP-332 SEDDS Suspension (Self-Emulsifying Drug Delivery System) |
| Concentration | 20 mg/mL |
| Bottle Volume | 50 mL — lasts exactly 50 days if dosed at 20 mg/day |
| Daily Starting Dose | 1 mL (20 mg); may be increased to 5 mL/day (100 mg) to test tolerance, however most stay on 20 mg/day for the duration and see great improvements |
| Timing | In the morning fasted, OR 1 hour prior to fasted cardio |
| Cycle Duration | 30 to 50 days continuous |
| Off-Cycle | 4 weeks completely off before starting another cycle (to allow metabolic pathways to normalize) |
| Handling & Storage | Shake well before use and store in the fridge at all times |
SLU-PP-332 belongs to a class of compounds known as exercise mimetics. It activates specific nuclear receptors called Estrogen-Related Receptors, which control metabolic gene networks. Based on preclinical animal models, the compound primarily targets three areas:
1. Upregulating Mitochondrial Biogenesis
SLU-PP-332 signals skeletal muscle cells to generate new mitochondria — the energy-producing centers of cells. An increased mitochondrial density enhances the muscle’s capacity to produce ATP efficiently, mimicking the cellular adaptations normally triggered by high-volume aerobic exercise.
2. Shifting Fuel Utilization (Fat Oxidation)
SLU-PP-332 alters cellular metabolism by forcing skeletal muscle to preferentially burn fatty acids for fuel rather than carbohydrates. By accelerating lipid oxidation, the body burns stored fat during baseline activity and aerobic exertion while conserving glycogen stores.
3. Enhancing Aerobic Endurance
Administration of SLU-PP-332 leads to significant increases in running distance and time to exhaustion. Because it enhances the oxidative capacity of type I (slow-twitch) muscle fibers, it supports sustained cardiovascular endurance and stamina without stimulating the central nervous system.
| Product | Bionix Labs Oral SLU-PP-332 SEDDS Suspension |
| Also known as | SLUPP332, SLU peptide |
| Formulation | Self-Emulsifying Drug Delivery System (SEDDS) |
| Concentration | 20 mg/mL |
| Bottle Volume | 50 mL |
| Route | Oral |
| Storage | Shake well; store in the fridge at all times |
| Ships to | Australia-wide |
It is a ready-to-use oral SLU-PP-332 suspension formulated as a Self-Emulsifying Drug Delivery System (SEDDS) at 20 mg/mL in a 50 mL bottle. It is taken orally — it is not reconstituted or mixed with BAC water.
Take 1 mL (20 mg) daily. The dose can be increased to 5 mL/day (100 mg) to test tolerance, however most users stay on 20 mg/day for the duration and see great improvements. Take it in the morning fasted, or 1 hour prior to fasted cardio.
A 50 mL bottle lasts exactly 50 days if dosed at 20 mg/day (1 mL).
Run SLU-PP-332 for 30 to 50 days continuous, then take 4 weeks completely off before starting another cycle to allow metabolic pathways to normalize.
Shake well before use and store in the fridge at all times.
Yes. Bionix Labs supplies the Oral SLU-PP-332 SEDDS Suspension for research purposes and ships Australia-wide with tracked standard or express post.
20 mg/mL · 50 mL · Oral SEDDS formulation · Tracked shipping Australia-wide.